MAP Ann: Microba Completes Dosing in Phase I IBD Clinical Trial - 25th Aug 2023, 8:55am

annb0t

annb0t

Top 20
MAP Ann: Microba Completes Dosing in Phase I IBD Clinical Trial
Price Sensitive: N
Date: 25th Aug 2023, 8:55am

>>> Read announcement: Google: MAP Market Announcements
 
You must log in or register to reply here.

Similar threads

annb0t
MAP Ann: Microba to acquire UK microbiome leader Invivo Clinical - 19th Oct 2023, 8:54am
Replies
0
Views
47
annb0t
annb0t
annb0t
MAP Ann: Microba to Present at 17th Bioshares Biotech Summit - 24th Jul 2023, 9:09am
Replies
0
Views
73
annb0t
annb0t
annb0t
MAP Ann: Microba Commences Phase I Clinical Trial for IBD Therapeutic - 28th Jun 2023, 9:04am
Replies
0
Views
95
annb0t
annb0t
annb0t
MAP Ann: MRFF Grant Awarded to QUT, In Collaboration With Microba - 27th Jun 2023, 11:17am
Replies
0
Views
87
annb0t
annb0t
annb0t
MAP Ann: Microba receives two AusIndustry Advanced Overseas Findings - 14th Jun 2023, 2:06pm
Replies
0
Views
116
annb0t
annb0t
Top Bottom